ARCHIMED acquires Jeisys Medical, a leading developer of aesthetic medicine devices, to capitalize on growth opportunities in the expanding South Korean market.
Information on the Target
Jeisys Medical is a prominent developer specializing in aesthetic medicine devices. The company is recognized for its innovative technology and commitment to enhancing the field of non-invasive procedures. Jeisys Medical has carved out a strong reputation with a diverse portfolio of medical devices aimed at delivering effective and safe treatments for various aesthetic concerns.
Since its inception, Jeisys Medical has demonstrated significant growth potential, marked by its dedication to research and development in aesthetic technologies. The company's strategic positioning within the industry has facilitated its expansion both domestically in South Korea and potentially in international markets.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in South Korea
The aesthetic medicine industry in South Korea is experiencing rapid growth, driven by an increasing demand for cosmetic procedures and advanced medical technology. South Korea has become a global leader in beauty and wellness, reco
Similar Deals
DKSH → Molecular Diagnostics Korea Inc. (MDxK)
2025
Bambu Ventures → Lemonaid Health
2026
ARCHIMED
invested in
Jeisys Medical
in
in a Buyout deal